ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,789.70
0.52%
S&P ASX All Technology
3,450.00
0.25%
Brent Oil
70.285
0.00%
US Dollar vs AUD
1.57978
-0.06%
Bitcoin
84,308.99
0.42%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Navidea Biopharmaceuticals Inc (NAVB)

  7. Navidea Biopharmaceuticals Inc (NAVB) News

NAVB

Navidea Biopharmaceuticals (NAVB)

Navidea Biopharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NAVB
DateTimeSourceHeadlineSymbolCompany
22/12/202307:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
06/12/202310:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
02/12/202303:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
17/11/202308:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
24/10/202304:56Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
06/10/202312:01Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockAMEX:NAVBNavidea Biopharmaceuticals Inc
06/10/202307:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
16/09/202305:42Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
11/09/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NAVBNavidea Biopharmaceuticals Inc
16/08/202307:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
12/08/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NAVBNavidea Biopharmaceuticals Inc
10/08/202323:29Business WireNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAMEX:NAVBNavidea Biopharmaceuticals Inc
09/08/202306:23Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
31/07/202323:32Business WireNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
29/07/202310:23Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationAMEX:NAVBNavidea Biopharmaceuticals Inc
29/07/202307:10Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
28/07/202307:20Business WireNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerAMEX:NAVBNavidea Biopharmaceuticals Inc
18/07/202308:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
18/07/202308:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
14/07/202307:27Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
14/07/202307:09Business WireNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownAMEX:NAVBNavidea Biopharmaceuticals Inc
07/07/202306:39Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
04/07/202307:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
04/07/202306:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
01/07/202306:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
01/07/202300:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:NAVBNavidea Biopharmaceuticals Inc
01/07/202300:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
30/06/202323:16Business WireNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsAMEX:NAVBNavidea Biopharmaceuticals Inc
17/06/202307:23Edgar (US Regulatory)Current Report Filing (8-k)AMEX:NAVBNavidea Biopharmaceuticals Inc
17/06/202307:00Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)AMEX:NAVBNavidea Biopharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:NAVB

Your Recent History

NASDAQI
TCHI
iShares MSCI China Multi...
COIN
PRQETH
Parsiq Token
LSE
49RR
Arran Res Baa
NASDAQ
FEVUX
Bmo Us Equity Growth Mfr...
TG
X88
Canadian Pacific Kansas ...
LSE
57UD
Finnvera 28
TSXV
MD
Midland Exploration
LSE
63NE
Stockholms 25
TG
M9X
WhiteHorse Finance
EU
CU2
Amundi Index Solutions
COIN
DMRUST
Dreamr Platform Token
USOTC
RVBR
Markray (PK)
TG
0L8
Lantheus
UNSW3
KNCETH
Kyber Network Crystal v2
LSE
73IJ
Sthn Gas 4.875%
LSE
56VM
Utd Utl Wt F 36
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads